• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int Urol Nephrol . Acid base disorders in patients with COVID-19

tetano

Editor, Senior Moderator
Int Urol Nephrol


. 2021 Jun 11.
doi: 10.1007/s11255-021-02855-1. Online ahead of print.
Acid base disorders in patients with COVID-19


Gaetano Alfano[SUP] 1 2 3 [/SUP], Francesco Fontana[SUP] 4 [/SUP], Giacomo Mori[SUP] 4 [/SUP], Francesco Giaroni[SUP] 5 [/SUP], Annachiara Ferrari[SUP] 5 [/SUP], Silvia Giovanella[SUP] 5 6 [/SUP], Giulia Ligabue[SUP] 5 [/SUP], Elisabetta Ascione[SUP] 4 [/SUP], Silvia Cazzato[SUP] 5 [/SUP], Marco Ballestri[SUP] 4 [/SUP], Margherita Di Gaetano[SUP] 7 [/SUP], Marianna Meschiari[SUP] 7 [/SUP], Marianna Menozzi[SUP] 7 [/SUP], Jovana Milic[SUP] 6 7 [/SUP], Bedini Andrea[SUP] 7 [/SUP], Erica Franceschini[SUP] 7 [/SUP], Gianluca Cuomo[SUP] 7 [/SUP], Riccardo Magistroni[SUP] 5 4 [/SUP], Cristina Mussini[SUP] 7 [/SUP], Gianni Cappelli[SUP] 5 4 [/SUP], Giovanni Guaraldi[SUP] 7 [/SUP], Modena Covid-19 Working Group (MoCo19)



Collaborators, Affiliations

Abstract

Purpose: Acid-base derangement has been poorly described in patients with coronavirus disease 2019 (COVID-19). Considering the high prevalence of pneumonia and kidneys injury in COVID-19, frequent acid-base alterations are expected in patients admitted with SARS-Cov-2 infection. The study aimed to assess the prevalence of acid-base disorders in symptomatic patients with a diagnosis of COVID-19.
Methods: The retrospective study enrolled COVID-19 patients hospitalized at the University Hospital of Modena from 4 March to 20 June 2020. Baseline arterial blood gas (ABG) analysis was collected in 211 patients. In subjects with multiple ABG analysis, we selected only the first measurement. A pH of less than 7.37 was categorized as acidemia and a pH of more than 7.43 was categorized as alkalemia.
Results: ABG analyses revealed a low arterial partial pressure of oxygen (PO[SUB]2[/SUB], 70.2 ± 25.1 mmHg), oxygen saturation (SO[SUB]2[/SUB], 92%) and a mild reduction of PO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio (231 ± 129). Acid-base alterations were found in 79.7% of the patient. Metabolic alkalosis (33.6%) was the main alteration followed by respiratory alkalosis (30.3%), combined alkalosis (9.4%), respiratory acidosis (3.3%), metabolic acidosis (2.8%) and other compensated acid-base disturbances (3.6%). All six patients with metabolic acidosis died at the end of the follow-up.
Conclusion: Variations of pH occurred in the majority (79.7%) of patients admitted with COVID-19. The patients experienced all the type of acid-base disorders, notably metabolic and respiratory alkalosis were the most common alterations in this group of patients.

Keywords: Acid lactic; Acid–base equilibrium; Alkalosis; Kidney disease; Metabolic acidosis; SARS-CoV-2.
 
Back
Top Bottom